1. Home
  2. ABAT vs EOLS Comparison

ABAT vs EOLS Comparison

Compare ABAT & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Battery Technology Company

ABAT

American Battery Technology Company

HOLD

Current Price

$3.98

Market Cap

522.9M

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.85

Market Cap

444.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABAT
EOLS
Founded
2011
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
522.9M
444.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ABAT
EOLS
Price
$3.98
$6.85
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.50
AVG Volume (30 Days)
5.6M
854.3K
Earning Date
02-13-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,025,853.00
$285,823,000.00
Revenue This Year
$145.40
$14.24
Revenue Next Year
N/A
$21.77
P/E Ratio
N/A
N/A
Revenue Growth
821.40
15.10
52 Week Low
$0.86
$5.71
52 Week High
$11.49
$17.12

Technical Indicators

Market Signals
Indicator
ABAT
EOLS
Relative Strength Index (RSI) 48.80 47.29
Support Level $3.61 $7.01
Resistance Level $4.43 $7.25
Average True Range (ATR) 0.38 0.24
MACD 0.04 -0.02
Stochastic Oscillator 42.35 18.49

Price Performance

Historical Comparison
ABAT
EOLS

About ABAT American Battery Technology Company

American Battery Technology Co is an integrated critical battery minerals company that develops technologies for both primary battery minerals manufacturing and lithium-ion battery recycling. It operates battery recycling facilities that process materials from electric vehicle batteries, stationary battery energy storage systems, and consumer electronics. Additionally, the company advances lithium production projects using proprietary technology to produce battery-grade lithium hydroxide. It generates revenue mainly from its recycling operations and is expanding capacity with strategic partnerships and government grants. The company's activities focus on creating a closed-loop battery materials supply chain to support sustainable manufacturing in the United States.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: